K. Erb-Zohar

Pharmacokinetics and safety of letermovir, a novel anti‐human cytomegalovirus drug, in patients with renal impairment

H. Stobernack, H. Zimmermann, A. Halabi, 2017, British journal of clinical pharmacology.

Pharmacokinetics and safety of the anti‐human cytomegalovirus drug letermovir in subjects with hepatic impairment

H. Stobernack, H. Zimmermann, D. Kropeit, 2017, British journal of clinical pharmacology.